121
Participants
Start Date
December 31, 2011
Primary Completion Date
June 30, 2014
Study Completion Date
December 31, 2014
Placebo
Normal Saline, Intravenous (IV), 0 mg, Once a week for the first week and every other week thereafter, 11 weeks
Placebo
Normal Saline, Intravenous, 0 mg, Every other week, Up to 337days
BMS-936557 (Anti-IP-10 Antibody)
Solution for IV administration, Intravenous, 10 mg/kg, Once a week for the first week and every other week thereafter, 11 weeks
BMS-936557 (Anti-IP-10 Antibody)
Solution for IV administration, Intravenous, 20 mg/kg, Once a week for the first week and every other week thereafter, 11 weeks
BMS-936557 (Anti-IP-10 Antibody)
Solution for IV administration, Intravenous, 7.5 mg/kg, Every other week, Up to 337 days
BMS-936557 (Anti-IP-10 Antibody)
Solution for IV administration, Intravenous, 15 mg/kg, Every other week, Up to 337 days
BMS-936557 (Anti-IP-10 Antibody)
Solution for IV administration, Intravenous, 15 mg/kg or optimal dose, Every other week, Open
Local Institution, Budapest
Local Institution, Budapest
Local Institution, Brussels
Local Institution, Leuven
Local Institution, Debrecen
Local Institution, Overport
Local Institution, Panorama
Local Institution, Claremont
Mount Sinai School Of Medicine, New York
Nyu Langone Long Island Clinical Research Associates, Great Neck
Local Institution, Nazareth
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr, Chevy Chase
University Of North Carolina At Chapel Hill, Chapel Hill
Local Institution, Haifa
Shafran Gasteroenterology Center, Winter Park
Local Institution, Pessac
Local Institution, Kfar Saba
Consultants For Clinical Research, Cincinnati
Local Institution, Vandœuvre-lès-Nancy
Midwest Center For Clinical Research, Lees Summit
Gastroenterology Research Of New Orleans, Hammond
Local Institution, Rouen
Gastroenterology Research Of San Antonio, San Antonio
Local Institution, Amiens
Southern California Medical Gastroenterology Group, Santa Monica
Local Institution, Clichy
Local Institution, Nice
Local Institution, Budapest
Local Institution, Krakow
Local Institution, Rzeszów
Local Institution, Warsaw
Local Institution, Warsaw
University Of Puerto Rico School Of Medicine, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY